Insider Selling: Tenet Healthcare (NYSE:THC) EVP Sells $1,549,795.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares in the company, valued at $6,983,853.13. This represents a 18.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Tenet Healthcare Trading Up 1.4%

Shares of NYSE THC opened at $227.79 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21. The business has a 50-day moving average price of $213.46 and a two-hundred day moving average price of $204.31. The firm has a market capitalization of $19.81 billion, a PE ratio of 14.71, a PEG ratio of 1.10 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the prior year, the firm earned $3.44 earnings per share. The firm’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on THC. Barclays increased their price objective on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Truist Financial upped their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Mizuho boosted their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday. KeyCorp raised their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research report on Thursday, February 12th. Finally, Jefferies Financial Group boosted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $250.56.

Institutional Investors Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its position in shares of Tenet Healthcare by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company’s stock valued at $1,488,484,000 after purchasing an additional 119,809 shares during the period. Boston Partners boosted its holdings in shares of Tenet Healthcare by 15.7% during the 4th quarter. Boston Partners now owns 3,642,136 shares of the company’s stock worth $723,804,000 after buying an additional 494,581 shares during the period. AQR Capital Management LLC grew its stake in Tenet Healthcare by 20.3% in the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company’s stock valued at $448,419,000 after buying an additional 380,116 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares during the period. Finally, Norges Bank bought a new stake in Tenet Healthcare during the fourth quarter valued at about $248,494,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.